|
Volumn 25, Issue 2, 2010, Pages 148-154
|
Management of anemia in heart failure.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIANEMIC AGENT;
IRON DERIVATIVE;
ANEMIA;
HEART FAILURE;
HOSPITALIZATION;
HUMAN;
INFLAMMATION;
IRON DEFICIENCY ANEMIA;
PATHOPHYSIOLOGY;
PRACTICE GUIDELINE;
PREVALENCE;
PROGNOSIS;
RENAL REPLACEMENT THERAPY;
REVIEW;
RISK FACTOR;
UNITED STATES;
ANEMIA;
ANEMIA, IRON-DEFICIENCY;
HEART FAILURE;
HEMATINICS;
HOSPITALIZATION;
HUMANS;
INFLAMMATION;
IRON COMPOUNDS;
PRACTICE GUIDELINES AS TOPIC;
PREVALENCE;
PROGNOSIS;
RENAL DIALYSIS;
RISK FACTORS;
UNITED STATES;
MLCS;
MLOWN;
|
EID: 77957556938
PISSN: None
EISSN: 15317080
Source Type: Journal
DOI: 10.1097/hco.0b013e3283357fe0 Document Type: Review |
Times cited : (12)
|
References (52)
|